Litcius/Paper detail

RETRACTED: Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study

Reinhard Dummer, Paola Queirolo, Ana Maria Abajo Guijarro, Youyou Hu, Dao Wen Wang, Sérgio Jobim Azevedo, Caroline Robert, Paolo A. Ascierto, Vanna Chiarion‐Sileni, P. Pronzato, Francesco Spagnolo, Karmele Mujika Eizmendi, Gabriella Liszkay, Luis de la Cruz‐Merino, Hussein A. Tawbi

2022The Lancet Oncology42 citationsDOI

Topics & Concepts

AtezolizumabVemurafenibMedicineCohortInternal medicineMelanomaOncologySurgeryMetastatic melanomaCancerImmunotherapyNivolumabCancer researchBrain Metastases and TreatmentMelanoma and MAPK PathwaysCutaneous Melanoma Detection and Management